| HOME >> BIOLOGY >> TECHNOLOGY |
(unaudited)
ASSETS
Current:
Cash and cash equivalents $80,022 $107,884
Marketable securities - 3,803
Prepaid and other assets 505 206
Total current assets 80,527 111,893
Property and equipment, net 1,717 3,357
Intellectual property, net 262 285
Total assets $82,506 $115,535
LIABILITIES AND STOCKHOLDERS' EQUITY
Current:
Accounts payable $2,187 $2,876
Accrued expenses:
Clinical trial expenses 1,164 1,560
Payroll and related 822 780
Accounting and legal fees 335 364
Severance expense - 355
Other 680 617
Taxes payable 95 170
Total current liabilities 5,283 6,722
Other long term liabilities - 141
Stockholders' equity:
Preferred stock, $0.01 par value; 50,000,000
shares authorized - -
Common stock, $0.01 par value; 100,000,000
shares authorized; 20,160,836 and 23,611,346
shares issued and outstanding, respectively 202 236
Additional paid-in capital 116,854 168,853
Deficit accum
'/>"/>
| SOURCE Biodel Inc. Copyright©2008 PR Newswire. All rights reserved |